MYNZ - Mainz Biomed N.V.
IEX Last Trade
0.3539
-0.009 -2.430%
Share volume: 670,607
Last Updated: Fri 30 Aug 2024 09:56:05 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$0.36
-0.01
-2.37%
Fundamental analysis
4%
Profitability
0%
Dept financing
0%
Liquidity
0%
Performance
10%
Performance
5 Days
-1.48%
1 Month
3.27%
3 Months
-51.01%
6 Months
-61.77%
1 Year
-88.11%
2 Year
-96.02%
Key data
Stock price
$0.35
DAY RANGE
N/A - N/A
52 WEEK RANGE
$0.31 - $4.38
52 WEEK CHANGE
-$0.88
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
Company detail
CEO:
Region: US
Website: mainzbiomed.com
Employees: 7
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services
Region: US
Website: mainzbiomed.com
Employees: 7
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services
mainz biomed is aiming to become a leading provider of easy-to-use diagnostic solutions for patients everywhere. we develop innovative products that quickly and easily identify the early onset of several leading deadly conditions including colorectal and pancreatic cancers. visit our website www.mainzbiomed.com to learn more about our company and our mission to save lives through science.
Recent news